The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety lead-in of phase II SBRT and durvalumab with or without tremelimumab for unresectable and cisplatin-ineligible, locally advanced or metastatic bladder cancer.
 
Palak Kundu
No Relationships to Disclose
 
Alan Lee
No Relationships to Disclose
 
Alexandra Drakaki
Employment - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I); Dyania Health (I)
Leadership - ATHOS THERAPEUTICS (I); ATTICA SCIENCES (I)
Stock and Other Ownership Interests - Alimera Sciences (I); Athos Therapeutics (I); ATTICA SCIENCES; Dyania Health (I); Kyn therapeutics (I); Moderna Therapeutics (I); PROTEAS BIOANALYTICS (I); Urogen pharma (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; DYANIA HEALTH; Exelixis; Janssen; Merck; PACT Pharma; RADMETRIX; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); BMS (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Jounce Therapeutics (Inst); Kite/Gilead; Merck Sharp & Dohme (Inst); Seattle Genetics/Astellas (Inst)
Patents, Royalties, Other Intellectual Property - My significant other has several patents with UCLA, Harvard Medical School, Athos Therapeutics, Proteas Bioanalytics and ATTICA Sciences (I)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Seagen
 
Sandy Liu
No Relationships to Disclose
 
John Shen
Consulting or Advisory Role - AstraZeneca
Research Funding - Ambrx (Inst); Arvinas (Inst); Bayer (Inst); BMS (Inst); Macrogenics (Inst); Merck (Inst)
 
Arnold I. Chin
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Johnson & Johnson/Janssen
Research Funding - Merck
 
Karim Chamie
Honoraria - Urogen pharma
Consulting or Advisory Role - ImmunityBio; Urogen pharma
Speakers' Bureau - Urogen pharma
Research Funding - Salix; Urogen pharma
 
Albert Chang
Stock and Other Ownership Interests - Myovant Sciences
Consulting or Advisory Role - Boston Scientific